SteelPeak Wealth LLC Takes $2.33 Million Position in HCA Healthcare, Inc. $HCA

SteelPeak Wealth LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, Holdings Channel.com reports. The fund bought 6,086 shares of the company’s stock, valued at approximately $2,332,000.

A number of other institutional investors have also made changes to their positions in the stock. KPP Advisory Services LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $217,000. Belpointe Asset Management LLC grew its stake in shares of HCA Healthcare by 5.7% during the second quarter. Belpointe Asset Management LLC now owns 2,347 shares of the company’s stock worth $899,000 after purchasing an additional 126 shares during the period. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Valeo Financial Advisors LLC grew its stake in shares of HCA Healthcare by 11.5% during the second quarter. Valeo Financial Advisors LLC now owns 1,129 shares of the company’s stock worth $433,000 after purchasing an additional 116 shares during the period. Finally, Simplicity Wealth LLC grew its stake in shares of HCA Healthcare by 92.7% during the second quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock worth $689,000 after purchasing an additional 865 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA opened at $437.46 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The firm has a market capitalization of $102.36 billion, a PE ratio of 18.39, a PEG ratio of 1.36 and a beta of 1.40. The business’s 50-day simple moving average is $401.26 and its 200 day simple moving average is $374.10.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the company posted $5.50 earnings per share. HCA Healthcare’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 12.11%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Truist Financial boosted their target price on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a research note on Wednesday, July 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a research note on Saturday, September 27th. Finally, Barclays upped their price objective on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $410.83.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.